scorecardresearch
Follow Us:
Tuesday, August 16, 2022

Neighbour’s pride

India stands to enhance its status as a responsible nation by supplying Covid vaccines to countries in South Asia.

By: Editorial |
Updated: January 21, 2021 8:51:48 am
Mamata Banerjee, Nandigram seat, West Bengal assembly election, BJP, TMC, Indian express newsShanta was more than a doctor, researcher and administrator — she saw herself as a healer.

Delhi’s decision to start sending vaccines to its neighbours in South Asia and other countries who have asked for it is the right step forward for India in its relations with its neighbours. It holds immense potential for a new kind of diplomacy in the region, one based on the common good and common interests of the South Asian people. As of now, India has shipped vaccines to Maldives, Bhutan, Bangladesh and Nepal, Myanmar and Seychelles, and will send them to other countries as well, including Sri Lanka and Afghanistan once approvals are available.

In doing so, Delhi is fulfilling its role as a responsible nation. With its advanced cutting-edge healthcare in the private sector, India attracts thousands of people from all countries of South Asia for medical treatment, at a fraction of what it costs in the West. Medicines manufactured in India have a good reputation across South Asia, even in Pakistan. It was natural then that governments in the region would look to vaccines manufactured in India, especially Covishield, developed by Oxford University and AstraZeneca, as a viable option. In their recent visits to neighbouring capitals, External Affairs Minister S Jaishankar and Foreign Secretary Harsh Shringla were asked about and gave assurances on the possibilities of vaccine supply from India. It is commendable that Delhi has moved quickly to deliver on commitments made to some of these countries. While the initial supplies have been sent free of cost, it is possible that countries may choose to enter into commercial agreements with the manufacturers for more quantities. The governments of Myanmar and Bangladesh are already in such negotiations.

For it to have any lasting value for Delhi’s relationships with its neighbours, it is best that India refrains from chest thumping a saviour complex. It would also be unwise to make this yet another contest between India and China. Vaccines are a global common good, and the demand for anti-COVID 19 immunisation across the world is massive. It is the responsibility of all countries with the capability to manufacture the vaccine to make it available internationally, and equitably to all. This is in every country’s interest, as building a global immunity to COVID19 is crucial to restoring the movement of people and goods across nations, to life as it was pre-pandemic. Even as they get supplies from India, expect South Asian countries to tie up part of their supplies from China, which has already entered into agreements to supply its vaccines to several countries in South East Asia and Pakistan. Eventually, it is the efficacy of each vaccine, irrespective of where it is made, that will matter.

 

Subscriber Only Stories
The rise of the worker productivity scorePremium
Delhi Confidential: Tiranga selfies campaign a big hit on Independence DayPremium
Bihar berozgari refrain makes way into CM’s job promisePremium
Collegium led by CJI Ramana cleared over 250 for HCs; vacancies now lowes...Premium

📣 Join our Telegram channel (The Indian Express) for the latest news and updates

For all the latest Opinion News, download Indian Express App.

  • Newsguard
  • The Indian Express website has been rated GREEN for its credibility and trustworthiness by Newsguard, a global service that rates news sources for their journalistic standards.
  • Newsguard
First published on: 21-01-2021 at 12:59:13 am
0 Comment(s) *
* The moderation of comments is automated and not cleared manually by indianexpress.com.

Featured Stories

Advertisement
Advertisement
Advertisement
Advertisement